Aligos Therapeutics
Clinical trials sponsored by Aligos Therapeutics, explained in plain language.
-
New pill shows promise in early hepatitis b trial
Disease control CompletedThis early-stage study tested a new oral drug called ALG-000184 in 165 people, including healthy volunteers and patients with chronic hepatitis B. The main goals were to check if the drug is safe and well-tolerated, and to see if it can lower hepatitis B virus levels in the blood…
Phase: PHASE1 • Sponsor: Aligos Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Liver function may affect how COVID drug works
Knowledge-focused CompletedThis study tested a new COVID-19 drug, ALG-097558, in 16 adults—some with moderate liver problems and some with healthy livers. The goal was to see how the liver affects drug levels in the body and check for side effects. It was an early-stage (Phase 1) study, not designed to mea…
Phase: PHASE1 • Sponsor: Aligos Therapeutics • Aim: Knowledge-focused
Last updated May 26, 2026 08:51 UTC
-
Kidney function may change how COVID drug works
Knowledge-focused CompletedThis study looked at how the experimental COVID-19 drug ALG-097558 is processed by the body in people with severe kidney problems compared to healthy volunteers. Twelve adults took the drug twice daily for several days. The goal was to measure drug levels in blood and urine, not …
Phase: PHASE1 • Sponsor: Aligos Therapeutics • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC